⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for osteoporosis

Every month we try and update this database with for osteoporosis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Evaluation of Outcomes for Quality of Life and Activities of Daily Living for BKP in the Treatment of VCFsNCT01871519
Compression Fra...
Osteoporosis
Cancer
Balloon kyphopl...
65 Years - Medtronic Spinal and Biologics
Sarcopenia and Risk of Falls in Patients With Major Chronic DiseasesNCT03798418
Stroke
Osteoporosis
Chronic Kidney ...
Cancer
elastic band st...
diet counseling
- Changhua Christian Hospital
Letrozole With or Without Zoledronate in Treating Healthy Postmenopausal Women With High Breast DensityNCT00114270
Breast Cancer
Osteoporosis
letrozole
zoledronic acid
18 Years - National Cancer Institute (NCI)
Guangzhou Nutrition and Health Study (GNHS)NCT03179657
Cardiovascular ...
Osteoporosis
Diabetes Mellit...
Metabolic Syndr...
Obesity
Hypertension
Non-Alcoholic F...
Chronic Kidney ...
Cancer
Death
Nutrition Disor...
Sarcopenia
40 Years - 83 YearsSun Yat-sen University
A Study of Romosozumab in Women With Multiple Myeloma and OsteoporosisNCT05775094
Multiple Myelom...
Osteoporosis
Romosozumab
18 Years - Memorial Sloan Kettering Cancer Center
Evaluation of PET/MR and PET/CT Imaging for Bone Marrow LesionsNCT01880762
Multiple Myelom...
Disease of the ...
Osteoporosis
30 Years - 80 YearsNYU Langone Health
One Week Comparison Study of PTH and PTHrP InfusionsNCT01333267
Osteoporosis
Hypercalcemia o...
Hyperparathyroi...
Bone Diseases, ...
Parathyroid Hor...
parathyroid hor...
PTH (1-34) and ...
24 Years - 35 YearsUniversity of Pittsburgh
Longitudinal Study of Bone Mineral Density in Survivors of Solid Pediatric CancersNCT00615485
Osteoporosis
7 Years - 40 YearsState University of New York - Upstate Medical University
PatientSpot Formerly Known as ArthritisPowerNCT03840928
Rheumatoid Arth...
Ankylosing Spon...
Fibromyalgia
Gout
Crohn Disease
Juvenile Idiopa...
Lupus Erythemat...
Myositis
Osteoarthritis
Osteoporosis
Psoriasis
Psoriatic Arthr...
Scleroderma
Dermatomyositis
Inflammatory Bo...
Polymyositis
Axial Spondyloa...
Diffuse Idiopat...
Polymyalgia Rhe...
Giant Cell Arte...
Temporal Arteri...
Wegener
Relapsing Polyc...
Undifferentiate...
Spinal Cord Inj...
Alzheimer Disea...
Amyotrophic Lat...
Ataxia
Bell Palsy
Brain Tumor
Cerebral Aneury...
Epilepsy
Guillain-Barre ...
Headache
Head Injury
Hydrocephalus
Lumbar Disc Dis...
Meningitis
Multiple Sclero...
Muscular Dystro...
Neurocutaneous ...
Parkinson Disea...
Stroke
Cluster Headach...
Tension-Type He...
Chronic Obstruc...
Asthma
Lung Cancer
Cystic Fibrosis
Sleep Apnea
Eczema
Alopecia
Chronic Inflamm...
Unstable Angina
Heart Attack
Heart Failure
Arrythmia
Valve Heart Dis...
High Blood Pres...
Congenital Hear...
Peripheral Arte...
Diabetes
Chronic Liver D...
Obesity
19 Years - Global Healthy Living Foundation
Exercise for Physical Health in Men With Prostate CancerNCT00660686
Prostatic Neopl...
Osteoporosis
Resistance Exer...
Flexibility Tra...
18 Years - 100 YearsOHSU Knight Cancer Institute
Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast CancerNCT00587925
Breast Cancer
Osteoporosis
Bone Mineral De...
- Memorial Sloan Kettering Cancer Center
Osteoporosis Among Men Treated With Androgen Deprivation for Prostate CancerNCT00957606
Prostate Cancer
Androgen Depriv...
Osteoporosis
blood sampling,...
- Odense University Hospital
Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate CancerNCT00176579
Osteoporosis
Prostate Cancer
dual x-ray abso...
50 Years - 75 YearsRutgers, The State University of New Jersey
An Open Label Non-Interventional Evaluation of the Effect of Adjuvant Hormonal Treatment of Postmenopausal Women Wih Early Breast Cancer With Aromatase Inhibitors on Bone Mineral Density and Bone Fracture Rate in Daily PracticeNCT00767585
Breast Cancer
Osteoporosis
55 Years - 65 YearsAstraZeneca
Swedish Mammography CohortNCT01127698
Cancers
Cardiovascular ...
Cataract
Gastrointestina...
Osteoporosis
Fractures
40 Years - 74 YearsKarolinska Institutet
One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation StudyNCT00580788
Osteoporosis
Humoral Hyperca...
Hyperparathyroi...
PTHrP (1-36)
24 Years - 35 YearsUniversity of Pittsburgh
Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02NCT00963417
Breast Cancer
Osteoporosis
laboratory biom...
dual x-ray abso...
18 Years - 120 YearsETOP IBCSG Partners Foundation
Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast CancerNCT00031811
Breast Cancer
Menopausal Symp...
Osteoporosis
raloxifene
quality-of-life...
- OHSU Knight Cancer Institute
Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98NCT00369850
Breast Cancer
Osteoporosis
laboratory biom...
Dual energy X-r...
Spine X-ray
30 Years - ETOP IBCSG Partners Foundation
Zoledronate in Treating Osteopenia or Osteoporosis in Postmenopausal Women Receiving Letrozole for Stage I, Stage II, or Stage IIIA Primary Breast CancerNCT00436917
Breast Cancer
Osteoporosis
zoledronic acid
Letrozole as ad...
18 Years - 120 YearsMayo Clinic
Intravenous Zoledronic Acid for the Treatment of Osteoporosis and Osteonecrosis in Children With Leukemia: A Pilot StudyNCT02632903
Osteoporosis
Osteonecrosis
Acute Lymphobla...
Zoledronic acid
8 Years - 16 YearsChildren's Hospital of Eastern Ontario
The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation TherapyNCT00063609
Prostate Cancer
zoledronic acid
18 Years - Novartis
Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast CancerNCT00022087
Breast Cancer
Osteoporosis
calcium salts
cholecalciferol
zoledronic acid
40 Years - Alliance for Clinical Trials in Oncology
Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant GliomaNCT00301873
Brain Tumors
Osteoporosis
Central Nervous...
IV Zometa
18 Years - Duke University
Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast CancerNCT00859703
Breast Cancer
Menopause
Osteopenia
Risedronate
Placebo
18 Years - Hospices Civils de Lyon
Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast CancerNCT00049452
Breast Cancer
Osteoporosis
zoledronic acid
18 Years - 50 YearsNational Cancer Institute (NCI)
Bone Microstructure by Using HR-pQCT After EsophagectomyNCT05812235
Osteoporosis
Sarcopenia
Esophageal Canc...
esophagectomy
50 Years - 90 YearsNagasaki University
99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and OsteoporosisNCT02304757
Differentiated ...
Osteoporosis
99Tc-MDP
Fosamax
45 Years - Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
The Bone-parathyroid Crosstalk in Primary HyperparathyroidismNCT05556499
Hyperparathyroi...
Osteoporosis
Parathyroid Neo...
Biomarker assay...
18 Years - I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate CancerNCT00043069
Osteoporosis
Prostate Cancer
calcium carbona...
cholecalciferol
Estrogen Antago...
risedronate sod...
placebo
18 Years - Alliance for Clinical Trials in Oncology
Impact of Allo-HSCT on Bone Remodeling: Evolution of Bone Mineral Density and Architecture Measured by Bone DensitometryNCT05161026
Myeloid Leukemi...
Bone osteodensi...
18 Years - 75 YearsUniversity Hospital, Caen
Outcome of Dental Implant Therapy in Patients Treated With Antiresorptive MedicationNCT04741906
Missing Teeth
Implants
Cancer
Osteoporosis
Dental implant ...
Prosthetic trea...
- Copenhagen University Hospital at Herlev
Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption?NCT00766532
Breast Cancer
Osteoporosis
Osteopenia
Fracture
Aromatase Inhib...
- University of Wisconsin, Madison
Zoledronate in Treating Osteopenia or Osteoporosis in Postmenopausal Women Receiving Letrozole for Stage I, Stage II, or Stage IIIA Primary Breast CancerNCT00436917
Breast Cancer
Osteoporosis
zoledronic acid
Letrozole as ad...
18 Years - 120 YearsMayo Clinic
Cohort of Swedish MenNCT01127711
Cancers
Cardiovascular ...
Cataract
Gastrointestina...
Osteoporosis
Fractures
45 Years - 79 YearsKarolinska Institutet
A Study of High-Dose Vit D Versus Standard of Care Vit D SupplementationNCT05016310
Breast
Breast Cancer
Osteoporosis
High Dose Vitam...
Standard of Car...
18 Years - 45 YearsWake Forest University Health Sciences
Exercise for Physical Health in Men With Prostate CancerNCT00660686
Prostatic Neopl...
Osteoporosis
Resistance Exer...
Flexibility Tra...
18 Years - 100 YearsOHSU Knight Cancer Institute
Intravenous Zoledronic Acid for the Treatment of Osteoporosis and Osteonecrosis in Children With Leukemia: A Pilot StudyNCT02632903
Osteoporosis
Osteonecrosis
Acute Lymphobla...
Zoledronic acid
8 Years - 16 YearsChildren's Hospital of Eastern Ontario
Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98NCT00369850
Breast Cancer
Osteoporosis
laboratory biom...
Dual energy X-r...
Spine X-ray
30 Years - ETOP IBCSG Partners Foundation
Myeloproliferative Neoplasms and Bone StructureNCT01816022
Polycythemia Ve...
Thrombocythemia...
Primary Myelofi...
18 Years - University of Southern Denmark
OsseoScrew Versus Fenestrated Pedicle Screws Augmented With PolymethylmethacrylateNCT01613144
Osteoporosis
Poor Bone Quali...
OsseoScrew Spin...
18 Years - Alphatec Spine, Inc.
Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-EffectsNCT00497458
Breast Cancer
Arthralgia
Osteoporosis
Testosterone
18 Years - 85 YearsHavah Therapeutics Pty Ltd
Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen DeprivationNCT00058188
Osteoporosis
Prostate Cancer
cholecalciferol
calcium glucona...
zoledronic acid
18 Years - Northwestern University
Women's Health Initiative (WHI)NCT00000611
Bone Diseases
Breast Neoplasm...
Cardiovascular ...
Colonic Neoplas...
Coronary Diseas...
Heart Diseases
Myocardial Isch...
Osteoporosis
Postmenopause
hormone replace...
estrogens
progestins
estrogen replac...
diet, fat-restr...
calcium
vitamin D
dietary supplem...
50 Years - 79 YearsNational Heart, Lung, and Blood Institute (NHLBI)
A Natural History Study of Bone and Mineral DisordersNCT00024804
Tumor Induced O...
Osteomalacia
Familial Tumora...
1 Day - National Institutes of Health Clinical Center (CC)
One Week Comparison Study of PTH and PTHrP InfusionsNCT01333267
Osteoporosis
Hypercalcemia o...
Hyperparathyroi...
Bone Diseases, ...
Parathyroid Hor...
parathyroid hor...
PTH (1-34) and ...
24 Years - 35 YearsUniversity of Pittsburgh
Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast CancerNCT00079248
Breast Cancer
Hot Flashes
Menopausal Symp...
Osteoporosis
therapeutic pro...
conjugated estr...
- National Cancer Institute (NCI)
Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-EffectsNCT00497458
Breast Cancer
Arthralgia
Osteoporosis
Testosterone
18 Years - 85 YearsHavah Therapeutics Pty Ltd
The Bone-parathyroid Crosstalk in Primary HyperparathyroidismNCT05556499
Hyperparathyroi...
Osteoporosis
Parathyroid Neo...
Biomarker assay...
18 Years - I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast CancerNCT00054418
Breast Cancer
Osteoporosis
calcium carbona...
vitamin D
risedronate sod...
placebo
18 Years - Alliance for Clinical Trials in Oncology
Prospective Study of Patients With Rheumatoid Arthritis After the Age of 65NCT02686320
Rheumatoid Arth...
18 Years - Assistance Publique - Hôpitaux de Paris
Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone LossNCT00925600
Cancer
Cataract
Low Bone Minera...
Osteopenia
Osteoporosis
Prostate Cancer
Denosumab
Placebo
30 Years - 120 YearsAmgen
Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast CancerNCT00859703
Breast Cancer
Menopause
Osteopenia
Risedronate
Placebo
18 Years - Hospices Civils de Lyon
Multi-centre Clinical Trial on Hormone Replacement Treatment in ChinaNCT01698164
Menopausal Synd...
Cardiovascular ...
Osteoporosis
Breast Cancer
estradiol plus ...
Ximingting Tabl...
estradiol plus ...
40 Years - 60 YearsPeking Union Medical College Hospital
Danish Osteoporosis Prevention StudyNCT00252408
Osteoporosis
Hormone replace...
45 Years - 58 YearsUniversity of Aarhus
Healthy Bones, Healthy Life: Habitual Physical Activity on Bone & Metabolic Health in Pediatric Cancer SurvivorsNCT04472286
Acute Lymphobla...
Pediatric ALL
Pediatric Lymph...
Bone Loss
Metabolic Syndr...
Habitual Physic...
Precursor Cell ...
Lymphoma
Leukemia
Lymphoid Leukem...
Pediatric
Osteoporosis
Osteoporosis Ri...
5 Years - 18 YearsUniversity of Nebraska
Women's Use of Alternative Medicine: A Multiethnic StudyNCT00067249
Uterine Fibroid...
Osteoporosis
Urinary Tract I...
High Blood Pres...
Heart Disease
Arthritis
Depression
Headaches
18 Years - National Center for Complementary and Integrative Health (NCCIH)
Fosamax for Childhood Cancer SurvivorsNCT00391404
Osteoporosis
Alendronate
Placebo
15 Years - Chinese University of Hong Kong
Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation TherapyNCT00129142
Prostate Cancer
Osteoporosis
Fractures
Toremifene Citr...
50 Years - GTx
Breast Cancer Women on Aromatase Inhibitors TreatmentNCT03811509
Osteoporosis
Osteoporosis Fr...
Arthralgia Gene...
bisphosphonate
40 Years - 80 YearsParc de Salut Mar
MoveStrong at Home: A Feasibility Study of a Model for Remote Delivery of Functional Strength and Balance Training Combined With Nutrition Education for Older Pre-frail Adults.NCT04663685
Arthritis
Cancer
Cardiovascular ...
Chronic Lung Di...
Congestive Hear...
Diabetes
Hypertension
Kidney Diseases
Obesity
Osteoporosis
Stroke
Frailty
Exercise progra...
Nutrition educa...
60 Years - University of Waterloo
Bicalutamide Monotherapy Has Significant Quality of Life Benefits for Men With Advanced Prostate CancerNCT00551044
Prostatic Neopl...
Bicalutamide
- Wirral University Teaching Hospital NHS Trust
Health and QoL in Oncological Patients: Management of Bone Pathology in Italian Citbl PopulationNCT04055805
Breast Cancer F...
Osteoporosis
Observational A...
18 Years - 75 YearsFondazione Policlinico Universitario Agostino Gemelli IRCCS
A Natural History Study of Bone and Mineral DisordersNCT00024804
Tumor Induced O...
Osteomalacia
Familial Tumora...
1 Day - National Institutes of Health Clinical Center (CC)
Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3NCT00688246
Breast Cancer
Osteoporosis
biologic sample...
dual x-ray abso...
35 Years - Canadian Cancer Trials Group
Bone Mineral Density and Subsequent Cancer RiskNCT00340262
Endometrial Can...
Breast Cancer
55 Years - 80 YearsNational Institutes of Health Clinical Center (CC)
Multi-centre Clinical Trial on Hormone Replacement Treatment in ChinaNCT01698164
Menopausal Synd...
Cardiovascular ...
Osteoporosis
Breast Cancer
estradiol plus ...
Ximingting Tabl...
estradiol plus ...
40 Years - 60 YearsPeking Union Medical College Hospital
Screening of Bone Mineral Density in Women Who Have Received ChemotherapyNCT00603551
Bone Density
Cancer
18 Years - Medical University of South Carolina
Fosamax for Childhood Cancer SurvivorsNCT00391404
Osteoporosis
Alendronate
Placebo
15 Years - Chinese University of Hong Kong
Fingernails in Evaluating Bone Health in Postmenopausal Women With Breast Cancer Undergoing Hormone Therapy on Clinical Trial IBCSG-1-98NCT00899288
Breast Cancer
Osteoporosis
spectroscopy
30 Years - ETOP IBCSG Partners Foundation
A Study of Romosozumab in Women With Multiple Myeloma and OsteoporosisNCT05775094
Multiple Myelom...
Osteoporosis
Romosozumab
18 Years - Memorial Sloan Kettering Cancer Center
Women's Health Initiative (WHI)NCT00000611
Bone Diseases
Breast Neoplasm...
Cardiovascular ...
Colonic Neoplas...
Coronary Diseas...
Heart Diseases
Myocardial Isch...
Osteoporosis
Postmenopause
hormone replace...
estrogens
progestins
estrogen replac...
diet, fat-restr...
calcium
vitamin D
dietary supplem...
50 Years - 79 YearsNational Heart, Lung, and Blood Institute (NHLBI)
99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and OsteoporosisNCT02304757
Differentiated ...
Osteoporosis
99Tc-MDP
Fosamax
45 Years - Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
One Week Comparison Study of PTH and PTHrP InfusionsNCT01333267
Osteoporosis
Hypercalcemia o...
Hyperparathyroi...
Bone Diseases, ...
Parathyroid Hor...
parathyroid hor...
PTH (1-34) and ...
24 Years - 35 YearsUniversity of Pittsburgh
Outcome of Dental Implant Therapy in Patients Treated With Antiresorptive MedicationNCT04741906
Missing Teeth
Implants
Cancer
Osteoporosis
Dental implant ...
Prosthetic trea...
- Copenhagen University Hospital at Herlev
Osteoporosis in Children With ALLNCT00330538
Leukemia, Lymph...
4 Years - 18 YearsChildren's Mercy Hospital Kansas City
A Natural History Study of Bone and Mineral DisordersNCT00024804
Tumor Induced O...
Osteomalacia
Familial Tumora...
1 Day - National Institutes of Health Clinical Center (CC)
Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor TherapyNCT00485953
Bone Loss
Osteoporosis
Breast Cancer
risedronate
55 Years - University of Pittsburgh
Screening of Bone Mineral Density in Women Who Have Received ChemotherapyNCT00603551
Bone Density
Cancer
18 Years - Medical University of South Carolina
Safety/Efficacy of Letrozole Monotherapy or in Combination With Zoledronic Acid as Extended Adjuvant Treatment of Postmenopausal Patients With Primary Breast CancerNCT00332709
Osteoporosis
Postmenopausal
Letrozole
Zoledronic acid
18 Years - Novartis
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: